January 9th - 2012

Future presentations at the EAU 2012

Pelvipharm at the EAU (European Association of Urology) in Paris, France, 24 - 28 February 2012.

Pelvipharm will present 3 posters:

• "Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)"
        D. Behr-Roussel, S. Oger, B. Pignol, E. Pham, A. Le Maux, P.E. Chabrier, P. Picaut, S. Caisey, S. Compagnie, F. Giuliano, P. Denys.
• "Evidence for a functional role of connexin 43 and 45 in human neurogenic detrusor overactivity"
       V. Phe, D. Behr-Roussel, S. Oger, E. Chartier-Kastler, T. Ghoneim, T. Lebret, G. Karsenty, E. Comperat, P. Camparo, P. Validire, F. Giuliano.
• "Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation with between clinical factors, urodynamics and histological features?"
        V. Phe, S. Oger, D. Behr-Roussel, P. Denys, E. Comperat, F. Giuliano, E. Chartier-Kastler.
  
  François Giuliano will present 1 poster:
  
  
• "Effects of tadalafil (TAD) or tamsulosin (TAM) on erectile function in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from a multicenter, double-blind, randomized, placebo (PLA)-controlled 12-week study"
        F. Giuliano; M. Oelke; V. Mirone; S. Watts; D. Cox; L. Viktrup
  
  

Delphine Behr-Roussel will chair the session 40 : "Sexual dysfunction: Basic research"

Please come and see us, we will be happy to discuss our results with you and potential applications for you.

February 10th - 2012

Bio-Europe Spring in Amsterdam, March 2012

Pelvipharm will be represented by Delphine Behr-Roussel at the next BIO-Europe Spring meeting in Amsterdam, March 19-21 2012. We warmly invite you to take this opportunity to learn more about our services.

If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.

January 2nd - 2012

Season's Greetings from the team at PELVIPHARM

We wish for you the very best for the new year, and extend our sincerest gratitude for your interest in our preclinical services.

September 29th - 2011

Recently published paper in Eur Urol

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG.
Eur Urol. 2011 Oct;60(4):809-25.

September 29th - 2011

Bio-Europe in Düsseldorf, October-November 2011

Pelvipharm will be represented by Delphine Behr-Roussel at the next Bio-Europe meeting in Düsseldorf, October 31 - November 2, 2011. We warmly invite you to take this opportunity to learn more about our services.

If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.

 

 

September 29th - 2011

Recently published paper in Int J Clin Pract

Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
Mirone V, Sessa A, Giuliano F, Berges R, Kirby M, Moncada I.
Int J Clin Pract. 2011 Sep;65(9):1005-13.